UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021-01, Vol.14, p.17562864211012835-17562864211012835

2021

Volltextzugriff (PDF)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Multiple sclerosis, 2021-05, Vol.27 (6), p.864-870

2021

Volltextzugriff (PDF)

Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis

Neurobiology of disease, 2023-01, Vol.176, p.105953-105953, Article 105953

2023

Volltextzugriff (PDF)

Gait analysis in multiple sclerosis: Characterization of temporal–spatial parameters using GAITRite functional ambulation system

Gait & posture, 2009-01, Vol.29 (1), p.138-142

2009

Volltextzugriff (PDF)

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Journal of neurology, 2022-05, Vol.269 (5), p.2286-2292

2022

Volltextzugriff (PDF)

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Neurobiology of disease, 2024-05, Vol.194, p.106475-106475, Article 106475

2024

Volltextzugriff (PDF)

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study

PloS one, 2023-02, Vol.18 (2), p.e0280515-e0280515

2023

Volltextzugriff (PDF)

Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis

PloS one, 2022-06, Vol.17 (6), p.e0264918

2022

Volltextzugriff (PDF)

Cerebral Cavernous Malformations

The New England journal of medicine, 2017-07, Vol.377 (1), p.71-71

2017

Volltextzugriff (PDF)

The effect of a telerehabilitation virtual reality intervention on functional upper limb activities in people with multiple sclerosis: a study protocol for the TEAMS pilot randomized controlled trial

Trials, 2020-08, Vol.21 (1), p.713-713, Article 713

2020

Volltextzugriff (PDF)

Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis

PloS one, 2016-10, Vol.11 (10), p.e0164467-e0164467

2016

Volltextzugriff (PDF)

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

International journal of infectious diseases, 2022-02, Vol.115, p.208-214

2022

Volltextzugriff (PDF)

Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis

Frontiers in psychology, 2019-07, Vol.10, p.1607

2019

Volltextzugriff (PDF)

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study

Scientific reports, 2022-12, Vol.12 (1), p.22158-6, Article 22158

2022

Volltextzugriff (PDF)

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study

PloS one, 2013-08, Vol.8 (8), p.e71058-e71058

2013

Volltextzugriff (PDF)

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy

Multiple sclerosis, 2019-11, Vol.25 (13), p.1746-1753

2019

Volltextzugriff (PDF)

Cognitive function in multiple sclerosis: A long-term look on the bright side

PloS one, 2019-08, Vol.14 (8), p.e0221784-e0221784

2019

Volltextzugriff (PDF)

Longitudinal relationships between disability and gait characteristics in people with MS

Scientific reports, 2022-03, Vol.12 (1), p.3653-3653, Article 3653

2022

Volltextzugriff (PDF)

The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors

Journal of neuroimmunology, 2012-11, Vol.252 (1), p.83-88

2012

Volltextzugriff (PDF)

Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors

Therapeutic advances in neurological disorders, 2022, Vol.15, p.17562864221109744-17562864221109744

2022

Volltextzugriff (PDF)

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

Journal of neuroinflammation, 2020-10, Vol.17 (1), p.1-313, Article 313

2020

Volltextzugriff (PDF)

Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a

Journal of neuroengineering and rehabilitation, 2021-12, Vol.18 (1), p.175-175, Article 175

2021

Volltextzugriff (PDF)

Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231194823-17562864231194823

2023

Volltextzugriff (PDF)

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

Drugs in R&D, 2023-12, Vol.23 (4), p.331-338

2023

Volltextzugriff (PDF)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211020082-17562864211020082

2021

Volltextzugriff (PDF)

1 – 25 von 296

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(221)

Publikationsform

Artikel
(294)
Berichte
(2)

Sprache

Englisch
(290)
Hebräisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis

Gait analysis in multiple sclerosis: Characterization of temporal–spatial parameters using GAITRite functional ambulation system

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study

Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis

Cerebral Cavernous Malformations

The effect of a telerehabilitation virtual reality intervention on functional upper limb activities in people with multiple sclerosis: a study protocol for the TEAMS pilot randomized controlled trial

Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy

Cognitive function in multiple sclerosis: A long-term look on the bright side

Longitudinal relationships between disability and gait characteristics in people with MS

The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors

Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a

Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Suchergebnisse filtern